Flu vaccine is produced by private manufacturers, so supply depends on manufacturers. Vaccine manufacturers originally projected that as many as 157 million to 168 million doses of injectable flu vaccine (i.e., inactivated and recombinant flu vaccines) would be made available for the 2016-2017 season.